Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Horizon Discovery on Sage Labs Acquisition

October 7, 2014

LONDON, 7 October, 2014 — Covington & Burling advised Horizon Discovery Group plc, an AIM listed international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, on the acquisition of Sage Labs Inc. for a total of approximately $48 million (£29 million), comprising up to $16 million in cash and up to $32 million in new ordinary shares.

The acquired business will be known as Sage Labs Inc., a wholly owned subsidiary of Horizon Discovery Group plc. The acquisition creates a fully integrated translational genomics platform and significantly expands Horizon’s product, service and research offerings.

The Covington team was led by partner Kristian Wiggert and associates Rabie Masri and Philip Young. The wider Covington team consisted of Paul Claydon and Simon Williams (UK Corporate), Mike Francese and Brady McDaniel (Employment and Benefits), Don Elliott (Environmental), Robin Blaney, Cynthia Burton, Angeliki Valsamidou, Marie Lavalleye and Jessica Milner (IP/Commercial), Jeannie Perron (Regulatory), Heather Haberl and Alex Kaplan (Real Estate), Rob Heller and Guy Dingley (Tax).

Share this article: